Klin Padiatr 2012; 224(01): 22-25
DOI: 10.1055/s-0031-1295437
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Cognitive Function in Patients with Epidermolysis Bullosa: Social Adjustment and Emotional Problems

Kognitive, soziale und emotionale Störungen bei Kindern und Jugendlichen mit Epidermolysis bullosa
R. Feldmann
1   University Hospital, Pediatrics, Münster, Germany
,
J. Weglage
1   University Hospital, Pediatrics, Münster, Germany
,
M. Frosch
1   University Hospital, Pediatrics, Münster, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
20 December 2011 (online)

Abstract

Background:

Children with Epidermolysis bullosa (EB) suffer from an intractable, burdensome skin disease that may result in cognitive as well as social and emotional problems.

Patients:

To assess cognitive problems in patients with EB, we investigated 20 affected children and adolescents, 6–17 years of age (mean: 10.8 years; SD: 3.4 years), and 24 healthy controls (6–15 years, mean: 10.9 years; SD: 3.0 years) for cognitive abilities. Additionally, parents were asked to assess social and emotional problems of their children.

Methods:

Patients and controls were assessed using the Wechsler Intelligence Scales. Parents completed Achenbach’s Child Behaviour Checklist (CBCL), a parent-report measure on emotional and behavioural symptoms in children.

Results:

The mean scores of the young patients tested with WISC-R and WAIS-R showed no significant left shift if compared to healthy controls. Analyzing the subtypes of EB, however, considerable cognitive deficits were associated with recessive dystrophic EB (RDEB), severe generalized. Less social competence and more social and emotional problems were reported for the entire patient group.

Conclusions:

Functional rehabilitation is required to increase not only the physical but the cognitive development of the severely affected children with RDEB. Children and adolescents with all subtypes of EB require therapeutic support regarding their social and emotional life.

Zusammenfassung

Hintergrund:

Für Kinder und Jugendliche bedeutet die Epidermolysis bullosa (EB) als nicht heilbare Erkrankung eine schwere Belastung, die zu kognitiven Störungen sowie zu sozialen und emotionalen Problemen führen kann.

Patienten:

Wir untersuchten 20 Patienten mit EB im Alter von 6–17 Jahren (M: 10,8 Jahre; SD: 3,4 Jahre) und eine Kontrollgruppe von 24 gesunden Kindern im Alter von 6–15 Jahren (M: 10,9 Jahre; SD: 3,0 Jahre) mit Testverfahren kognitiver Fähigkeiten. Die Eltern beider Stichproben schätzten soziale Aktivitäten sowie soziale und emotionale Auffälligkeiten ihrer Kinder ein.

Methode:

Für die Untersuchung von Patienten und Kontrollgruppe nutzten wir die Wechsler-Intelligenztests für Kinder und Erwachsene. Soziale und emotionale Auffälligkeiten wurden mit der Child Behaviour Checklist (CBCL) erfasst.

Ergebnisse:

Kinder und Jugendliche mit EB erbrachten im Vergleich mit der Kontrollgruppe keine signifikant schlechteren Testergebnisse. Beträchtliche kognitive Defizite zeigten jedoch Patienten mit schwerer, generalisierter rezessiv-dystrophischer EB (RDEB). Geringere soziale Kompetenz und vermehrte soziale und emotionale Auffälligkeiten wurden für die gesamte Patientengruppe der Kinder und Jugendlichen mit EB berichtet.

Schlussfolgerung:

Kinder und Jugendliche mit EB brauchen aufgrund ihrer teilweise erheblichen kognitiven Defizite gute fachliche Förderung. Zugleich ist diese schwere, chronische Erkrankung verbunden mit sozialen und emotionalen Problemen der jungen Patienten, die ihrerseits guter therapeutischer Begleitung bedürfen.

 
  • References

  • 1 Achenbach TM. Manual for the Child Behaviour Checklist/4-18 and 1991 profile. Burlington, Vermont: University of Vermont Department of Psychiatry; 1991
  • 2 Andreoli E, Mozzeta A, Angelo C et al. Epidermolysis bullosa. Psychological and psychosocial aspects. Dermatol Psychosom 2002; 3: 77-81
  • 3 Ayman T, Yerebakan O, Ciftcioglu MA et al. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma. Pediatr Dermatol 2002; 19: 436-438
  • 4 Bello YM, Falabella AF, Schachner LA. Management of epidermolysis bullosa in infants and children. Clin Dermatol 2003; 21: 278-282
  • 5 Birge K. Nutrition management of patients with epidermolysis bullosa. J Am Diet Assoc 1995; 95: 575-579
  • 6 Bruckner-Tudermann L, Höpfner B, Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 1999; 18: 43-54
  • 7 Bruckner-Tuderman L. Epidermolysis bullosa care in Germany. Dermatol Clin 2010; 28: 405-406
  • 8 Castillo RO, Davies YK, Lin YC et al. Management of oesophageal strictures in children with recessive dystrohic epidermolysis bullosa. J Pediatr Gastroenterol Nutr 2002; 34: 535-541
  • 9 Fasulakis S, Andronikou S. Balloon dilatation in children for oesophageal strictures other than those due to primary repair of oesophageal atresia, interposition or restrictive fundoplication. Pediatr Radiol 2003; 33: 682-687
  • 10 Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis 2011; 5: 12
  • 11 Fine JD, Eady RAJ, Bauer EA et al. The classification of inherited epidermolysis bullosa (EB): Report of the Tird International Consensus Meeting on diagnosis and classsification of EB. J Am Acad Dermatol 2008; 58: 938-950
  • 12 Fine JD, Johnson LB, Weiner M et al. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clin Exp Dermatol 2004; 29: 122-127
  • 13 Fine JD, Johnson LB, Weiner M et al. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status, and family size. Br J Dermatol 2005; 152: 1009-1014
  • 14 Fine JD, Johnson LB, Weiner M et al. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr 2008; 46: 147-158
  • 15 Fine JD, Johnson LB, Weiner M et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009; 60: 203-211
  • 16 Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part II. Other organs. J Am Acad Dermatol 2009; 61: 387-402
  • 17 Glicenstein J, Mariani D, Haddad R. The hand in recessive dystrophic epidermolysis bullosa. Hand Clin 2000; 16: 637-645
  • 18 Göbel U, Gortner L. Disease management programs for adults with often diseases and competence networks for children and adolescents with rare diseases. Klin Padiatr 2011; 223: 1-3
  • 19 Goldbeck L, Hölling I, Schlack R et al. The impact of an inpatient family-oriented rehabilitation program on parent-reported psychological symptoms of chronically ill children. Klin Padiatr 2011; 223: 79-84
  • 20 Guerriero C, De Simone C, Venier A et al. Non-Herlitz junctional epidermolysis bullosa without hair involvement associated with BP180 deficiency. Dermatology 2001; 202: 58-62
  • 21 Hauschild R, Wollina U, Bruckner-Tuderman L. Junctional epidermolysis bullosa gravis (Herlitz): diagnostic and genetic aspects. J Eur Acad Dermatol Venereol 2001; 15: 73-76
  • 22 Horn HM, Tidman MJ. The clinical spectrum of epidermolysis bullosa simplex. Br J Dermatol 2000; 142: 468-472
  • 23 Horn HM, Tidman MJ. Quality of life in epidermolysis bullosa. Clin Exp Dermatol 2002; 27: 707-710
  • 24 Horn HM, Tidman MJ. The clinical spectrum of dystrophic epidermolysis bullosa. Br J Dermatol 2002; 146: 267-274
  • 25 Ivanovic DM, Leiva BP, Perez HT et al. Head size and intelligence, learning, nutritional status and brain development Head, IQ, learning, nutrition and brain. Neuropsychologia 2004; 42: 1118-1131
  • 26 Klingebiel T, Creutzig U, Christaras A et al. Milestones of health policy and rare diseases. Klin Padiatr 2010; 222: 121-123
  • 27 Lansdown R, Atherton D, Dale A et al. Practical and psychological problems for parents of children with epidermolysis bullosa. Child Care Health Dev 1986; 12: 251-256
  • 28 Schara U, Mortier W, Rouan F et al. Severe muvous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel gene mutation. Eur J Pediatr 2004; 163: 218-222
  • 29 Travis SPL, McGrath JA, Turnbull AJ et al. Oral and gastrointestinal manifestations of epidermolysis bullosa. Lancet 1992; 340 () 1505-1506
  • 30 Uitto J, Richard G. Progress in epidermolysis bullosa: genetic classification and clinical implications. Am J Med Genet C Semin Med Genet 2004; 131C: 61-74
  • 31 Wechsler D. Wechsler Intelligence Scales for Children – Revised. San Antonio, Texas: The Psychological Corporation; 1974
  • 32 Wechsler D. Wechsler Adult Intelligence Scale – Revised. Cleveland, Ohio: The Psychological Corporation; 1981
  • 33 West CA, Besier T, Borth-Bruhns T et al. Effectiveness of a family-oriented rehabilitation program on the quality of life of parents of chronically ill children. Klin Padiatr 2009; 221: 241-246
  • 34 Zimmer KP, Schumann H, Mecklenbeck S et al. Esophageal stenosis in childhood: dystrophic epidermolysis bullosa without skin blistering due to collagen VII mutations. Gastroenterology 2002; 122: 220-225